Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2003
08/21/2003CA2476383A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2476131A1 Composition for skin healing comprising a chitosan hydrogel
08/21/2003CA2476113A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2474171A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1336654A1 Method of treating psoriasis using anti-gamma interferon antibody
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1336402A1 Association of diguanosine tetraphosphate and nicotinic derivatives used for the treatment of capillary disorders, in particular the treatment of hair loss
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335743A1 Inhibition or reversal of skin aging by actin-sequestering peptides
08/20/2003EP1335740A1 Method and preparations having effect against allergic symptoms
08/20/2003EP1335719A1 Treating eczema and/or psoriasis
08/20/2003EP1335701A2 Anti-adiposis topical treatment composition based on garlic bulb extracts
08/20/2003EP1335700A1 Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic or dermatological use
08/20/2003EP1335699A2 Concordantly uv-photoprotecting and artificial tanning compositions
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0866693B1 Topically applied, structural cellulite treatments
08/20/2003EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003EP0725772B1 Phytosphingosine-based ceramide i analogs
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437608A O-aryl glucoside SGL T2 inhibitors and method
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437475A Combined cartilage and plant extract composition
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1437461A Cosmetic or dermatological cream composition, the preparation and the use thereof
08/20/2003CN1437449A Physiologically active agents containing vicinal dithioglycols and use therof in various branches of economy
08/20/2003CN1436567A Burn treating medicine powder
08/20/2003CN1436563A Skin-cleaning and itch-stopping tincture as externally applied medicine for treating skin pruritus
08/20/2003CN1436557A Disinfectant
08/20/2003CN1436520A Antiscurf and antiitch composition containing sensory agent and sensory intensifier compound
08/20/2003CN1118290C Chinese herb medicine preparaiton for hair growth
08/20/2003CN1118284C Medicinal composition for treating beriberi and preparing process thereof
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608103 Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608087 Gyrase inhibitors and uses thereof
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607735 Method for reducing the appearance of dark circles under the eyes
08/19/2003CA2260337C Therapeutic agents
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066631A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066572A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003WO2003066205A2 Microcapsules having high carotenoid content
08/14/2003WO2003066100A1 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066073A2 Compositions containing oat straw and willowherb extract
08/14/2003WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
08/14/2003WO2003066064A2 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066046A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066012A1 Preparations containing diol
08/14/2003WO2003066008A1 Method of enhancing hair growth
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003066001A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 1065